154 related articles for article (PubMed ID: 33632468)
21. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
[TBL] [Abstract][Full Text] [Related]
22. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
Johnston KL; Ford L; Taylor MJ
J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
[TBL] [Abstract][Full Text] [Related]
23. Finding new hits in neglected disease projects: target or phenotypic based screening?
Gilbert IH; Leroy D; Frearson JA
Curr Top Med Chem; 2011; 11(10):1284-91. PubMed ID: 21401505
[TBL] [Abstract][Full Text] [Related]
24. High-throughput screening for kinase inhibitors.
von Ahsen O; Bömer U
Chembiochem; 2005 Mar; 6(3):481-90. PubMed ID: 15742384
[TBL] [Abstract][Full Text] [Related]
25. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
26. From Yeast to Humans: Leveraging New Approaches in Yeast to Accelerate Discovery of Therapeutic Targets for Synucleinopathies.
Piotrowski JS; Tardiff DF
Methods Mol Biol; 2019; 2049():419-444. PubMed ID: 31602625
[TBL] [Abstract][Full Text] [Related]
27. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
28. Repurposing strategies for tropical disease drug discovery.
Klug DM; Gelb MH; Pollastri MP
Bioorg Med Chem Lett; 2016 Jun; 26(11):2569-76. PubMed ID: 27080183
[TBL] [Abstract][Full Text] [Related]
29. Application of shape-based and pharmacophore-based in silico screens for identification of Type II protein kinase inhibitors.
Mucs D; Bryce RA; Bonnet P
J Comput Aided Mol Des; 2011 Jun; 25(6):569-81. PubMed ID: 21681554
[TBL] [Abstract][Full Text] [Related]
30. Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
Valenciano AL; Ramsey AC; Santos WL; Mackey ZB
Bioorg Med Chem; 2016 Oct; 24(19):4647-4651. PubMed ID: 27519462
[TBL] [Abstract][Full Text] [Related]
31. Fluorescent biosensors - probing protein kinase function in cancer and drug discovery.
Morris MC
Biochim Biophys Acta; 2013 Jul; 1834(7):1387-95. PubMed ID: 23376184
[TBL] [Abstract][Full Text] [Related]
32. Baker's yeast as a tool for the development of antifungal kinase inhibitors--targeting protein kinase C and the cell integrity pathway.
Heinisch JJ
Biochim Biophys Acta; 2005 Dec; 1754(1-2):171-82. PubMed ID: 16216564
[TBL] [Abstract][Full Text] [Related]
33. Infectious diseases. Drug developers finally take aim at a neglected disease.
Leslie M
Science; 2011 Aug; 333(6045):933-5. PubMed ID: 21852468
[No Abstract] [Full Text] [Related]
34. [Activity of NTDs Drug-discovery Research Consortium].
Namatame I
Yakugaku Zasshi; 2016; 136(2):231-6. PubMed ID: 26831798
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive screening of human genes with inhibitory effects on yeast growth and validation of a yeast cell-based system for screening chemicals.
Sekigawa M; Kunoh T; Wada S; Mukai Y; Ohshima K; Ohta S; Goshima N; Sasaki R; Mizukami T
J Biomol Screen; 2010 Apr; 15(4):368-78. PubMed ID: 20237203
[TBL] [Abstract][Full Text] [Related]
36. Actives from MMV Open Access Boxes? A suggested way forward.
Samby K; Willis PA; Burrows JN; Laleu B; Webborn PJH
PLoS Pathog; 2021 Apr; 17(4):e1009384. PubMed ID: 33886696
[TBL] [Abstract][Full Text] [Related]
37. Type I methionine aminopeptidase from Saccharomyces cerevisiae is a potential target for antifungal drug screening.
Chen LL; Li J; Li JY; Luo QL; Mao WF; Shen Q; Nan FJ; Ye QZ
Acta Pharmacol Sin; 2004 Jul; 25(7):907-14. PubMed ID: 15210064
[TBL] [Abstract][Full Text] [Related]
38. Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation.
Astolfi A; Kudolo M; Brea J; Manni G; Manfroni G; Palazzotti D; Sabatini S; Cecchetti F; Felicetti T; Cannalire R; Massari S; Tabarrini O; Loza MI; Fallarino F; Cecchetti V; Laufer SA; Barreca ML
Eur J Med Chem; 2019 Nov; 182():111624. PubMed ID: 31445234
[TBL] [Abstract][Full Text] [Related]
39. Doing more than just the structure-structural genomics in kinase drug discovery.
Marsden BD; Knapp S
Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
[TBL] [Abstract][Full Text] [Related]
40. Computer-aided discovery of aminopyridines as novel JAK2 inhibitors.
Zhao C; Yang SH; Khadka DB; Jin Y; Lee KT; Cho WJ
Bioorg Med Chem; 2015 Mar; 23(5):985-95. PubMed ID: 25650310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
